Scientists design two mucosal probiotic vaccine candidates

The Vaccine Prevention Laboratory has designed two mucosal probiotic vaccine
candidates using the N protein of the SARS-CoV-2 virus as the vaccine antigen.
Vaccine candidates are highly immunogenic and vaccinated laboratory animals
produce specific antibodies against SARS-Cov-2 for a long time. It is assumed
that such vaccines will be protective against any variants of coronavirus.

22.03.2023